Endothelial cells, either in vivo or freshly isolated, respond when exposed to muscarinic agonists with an increase in cytosolic free calcium concentration ([Ca2"];) and release of endothelium-derived relaxing factor (EDRF). When F urchgott and Zawadzki1 were the first to demonstrate the phenomenon of endotheliumdependent relaxation of blood vessels while using acetylcholine. These investigators,1 as well as others,2-5 established that the ability of acetylcholine to elicit the release of endothelium-derived relaxing factor (EDRF) was mediated through a muscarinic receptor-linked pathway.
of endothelial muscarinic receptors. 89 Other studies in which classic pharmacological approaches were used have classified the receptor responsible for mediating endothelium-dependent relaxation as M245 or M3,3,ll whereas a study that examined isolated endothelial cells identified a muscarinic receptor of the M, subtype. '2 In the present study, we chose to use a different approach, that of Northern blot analysis, to answer the questions regarding the existence of endothelial muscarinic receptors and the identity of the receptor subtypes present on the endothelium. We addressed the hypothesis that muscarinic receptors are expressed by endothelial cells, but the subtype(s) responsible for coupling acetylcholine to EDRF production is no longer expressed once the cells are placed in culture.
Materials and Methods

Muscarinic Receptor Subtype-Specific cDNA Probes
Muscarinic receptor subtype-specific partial cDNA probes for the nonconserved third intracellular (i3) loop of the ml-m5 receptor subtypes were a gift from T. Bonner (Laboratory of Cell Biology, National Institute of Mental Health). The ml (390-bp) and m4 (520-bp) probes were Bal I/Xma I fragments of the i3 loop of the rat ml and m4 clones. 13 The m2 probe was a 500-bp Ava I fragment of the i3 loop of the human m2 clone; the m3 probe was a 700-bp Stu I/Nhe I fragment of the i3 loop of the rat m3 clone. 13 The m5 probe was a 500-bp Bgl II/BamHI fragment of the i3 loop of the rat m5 clone.14 Harvesting and Culture of Endothelium Endothelial cells were harvested from bovine aortas as previously described,15 with minor modifications. Harvested cells were initially plated in six-well culture plates and grown to confluence in Waymouth's MB media (GIBCO Laboratories, Grand Island, N.Y.) containing 10% fetal bovine serum (Hyclone Laboratories Inc., Logan, Utah), 0.1 mg/ml L-glutamine, and 1% penicillin/streptomycin, pH 7.4. Endothelial cell cultures were maintained at 37°C in 95% room air-5% CO2. The cell cultures were split and amplified in 25-cm2 culture flasks, followed by fluorescent labeling with Dil-acetylated low density lipoprotein15 and sorting using a fluorescence-activated cell sorter (EPICS Dye Laser System, Coulter Corp., Hialeah, Fla. RNA from rat brain served as a positive control in experiments in which the ml, m3, m4, and m5 cDNA probes were used; poly(A) + RNA from rat atria was used as a positive control during hybridization with the m2 cDNA probe. In each case, total RNA from rat liver served as a negative control. The poly(A)+ RNA samples were subjected to electrophoresis through a 1.0% agarose gel containing 2.2 M formaldehyde and lx Northern buffer. After removing the lane containing the RNA ladder from the remainder of the gel, molecular weight standards were visualized using ethidium bromide. The gel was rinsed in 20x SSPE (1 x SSPE is 0.i1 M sodium chloride, 0.017 M sodium phosphate, and 0.001 M EDTA, pH 7.4) for 30 minutes, followed by transfer of the RNA to a 0.45-gim nylon membrane (Fisher Scientific, Pittsburgh, Pa.) by Northern blotting (using 10x SSPE). The resulting blot was irradiated ultravioletly to cross-link the RNA to the membrane and then baked at 80°C, under vacuum, for 4 hours. Dot blots were prepared by the method of Zeng and Lynch18 using the ml-m5 plasmid DNAs and a dot blot template (Schleicher & Schuell, Inc., Keene, N.H.). Thirty femtomoles (8-14 ng) of DNA was introduced into each well.
Labeling of cDNA Probes and Hybridization Conditions cDNA probes for the ml-mS receptor subtypes or a near full-length (i.e., coding region-and noncoding region-containing) smooth muscle a-actin cDNA from a rat stomach cDNA library (provided by K. ( 10 minutes per wash); blots probed with the smooth muscle a-actin cDNA were washed twice with wash buffer A and four to six times with wash buffer B. All blots were rinsed with 25 mM sodium phosphate buffer (pH 7.0) before being air-dried. Membranes were exposed to Kodak X-Omat AR film at -70°C in the presence of intensifying screens.
Results
Specificity of Muscarinic Receptor cDNA Probes
Under the defined hybridization conditions used in the present study, the five different muscarinic receptor i3 loop cDNA probes were demonstrated to be subtype specific (i.e., each hybridized only to a single cDNA) (Figure 1 ).
Muscarinic Receptor mRNA Expression in Endothelial Cells and Vascular Smooth Muscle mRNA transcripts for ml, m2, and m3 receptor subtypes were detected in freshly isolated endothelial cells (Figure 2) . The transcripts were approximately 3.9 kb (ml), 3.8 kb (m2), and 3.1 kb (m3) in size. ml and m3 receptor transcripts were detected also in bovine aortic vascular smooth muscle (Figure 2 ). In ml m2 m3 the cultured endothelial cells, mRNA for the m2 receptor was observed (Figure 2 ). In contrast to the results obtained with freshly isolated endothelial cells, transcripts for the ml or m3 subtypes were not present in the cultured endothelial cells (Figure 2 ). Complementary mRNA sequences for the m4 and m5 muscarinic receptor cDNA probes were not detected in either the freshly isolated or cultured endothelial cells (Figure 3 ). Although the hybridization signals for the ml and m3 receptor transcripts in the brain appear somewhat diffuse (Figure 2) , this reflects the exposure time necessary to detect the endothelial cell mRNA transcripts. Since the lanes were loaded with equivalent quantities of poly(A)+ RNA, as demonstrated by the comparable f3-actin hybridization signals for each tissue (Figure 4 ), the ml and m3 receptor mRNAs appear to be significantly less abundant in the endothelial cells than in the brain (Figure 2 ). Shorter exposure times yielded a single well-defined band in each control tissue, except in the case of the ml cDNA-labeled blots, where a second minor band was evident in the brain at a position corresponding to that of the 28S ribosomal subunit. It To control for the possibility that the ml and m3 hybridization signals detected in freshly isolated endothelial cells represented contamination of the preparations by vascular smooth muscle, the blots were rehybridized with a full-length cDNA probe for smooth muscle a-actin. Cross-hybridization of the cDNA probe to /-actin (2.1 kb) in each tissue demonstrated that equivalent quantities of mRNA were loaded into each lane of the gel (Figure 4) . a-Actin mRNA (1.7 kb) was detected in the vascular smooth muscle, whereas only minor amounts were detected in the freshly isolated endothelial cell preparations; cultured endothelial cell preparations did not contain a-actin (Figure 4) . Based on the relative densities of the respective a-actin bands, a conservative estimate is that <1% of the ml and m3 transcripts detected in the freshly isolated endothelial cells can be attributed to the presence of vascular smooth muscle in the preparations.
Discussion
Endothelial cells, when either present on the intimal surface of an isolated blood vessell2 or when freshly isolated, [21] [22] [23] Previous studies have classified the receptor subtype responsible for mediating endothelium-dependent relaxation as either M245 or M3,31'' whereas M1 receptors have been identified on isolated endothelial cells.12 (The M, M2, and M3 pharmacological classification of muscarinic receptors based on the use of selective agonists/antagonists appears to be equivalent to the ml, m2, and m3 molecular classification of these receptors.26) However, there are other studies in which muscarinic receptors have not been detected on endothelial cells.8,9 To circumvent some of the difficulties associated with autoradiographic or pharmacological approaches to the identification of endothelial muscarinic receptors, we decided to use Northern blot analysis to establish clearly whether endothelial cells possess muscarinic receptors and, if so, the identity of the expressed receptor subtypes.
In the present study, mRNA for the ml, m2, and m3 muscarinic receptor subtypes was identified in freshly isolated bovine aortic endothelial cells. However, once placed in culture, the endothelial cells (by fourth passage) failed to contain detectable mRNA for the ml and m3 receptors, whereas they retained mRNA for the m2 receptor subtype. Similar results were obtained in a recent pharmacological study by Brunner and Kukovetz,'2 although these investigators detected only the presence of M1 receptors on bovine aortic endothelial cells. Thus, Northern blot analysis provides an independent and perhaps more sensitive method with which to examine endothelial muscarinic receptor expression.
Bovine muscarinic receptor mRNAs have not been characterized previously. Our data indicate that the sizes of the various muscarinic receptor transcripts detected in the bovine endothelial cells and vascular smooth muscle differ from the sizes of those detected in the rat brain and atria. The sizes of the muscarinic receptor transcripts detected in the rat brain and atria corresponded to those reported previously. 27, 28 The mRNA transcripts for the ml and m3 receptors detected in the freshly isolated endothelial cells were not due to contamination by the vascular smooth muscle. This was demonstrated by the relative amounts of the muscarinic receptor mRNA compared with the amount of a-actin mRNA present in each preparation. It should be noted that the films from blots that were hybridized with the smooth muscle a-actin cDNA probe required extensive overexposure to detect any evidence of smooth muscle contamination in the freshly isolated endothelial cell preparations. These experiments also demonstrated the purity of the cultured endothelial cell preparations. Therefore, our data indicate that freshly isolated endothelial cells, in contrast to cultured endothelial cells, do in fact express ml and m3 receptor mRNA transcripts. Additional studies are required to distinguish between failure of transcription and destabilization of mRNA for the ml and m3 receptors during culture.
Our observations provide a possible explanation for the inability of muscarinic agonists to elicit EDRF release from cultured endothelial cells. Although the signal transduction pathways in the endothelium through which ml and m3 receptors are coupled have not been elucidated, agonist binding to these receptors in various cell types leads to the activation of phospholipase C.29-32 Endothelium-dependent va-sodilators stimulate phospholipase C and inositol 1,4,5-trisphosphate production in endothelial cells, followed by inositol 1,4,5-trisphosphate-dependent release of calcium from intracellular stores.33-36 Therefore, it would seem reasonable to suggest that cultured endothelial cells no longer respond to muscarinic agonist stimulation with either a rise in [Ca2"] or EDRF release because of the loss of the ml and/or m3 muscarinic receptor.
Based on conceptual problems associated with the hypothesis that the endothelium expresses muscarinic receptors (i.e., very little acetylcholine is present in the blood, or little direct evidence for innervation of the endothelium) and the outcome of several studies that have failed to demonstrate the presence of endothelial muscarinic receptors, a theory has been advanced that proposes that muscarinic agonists act on vascular smooth muscle to release a mediator that is then responsible for stimulating the endothelium to release EDRF.8 Although not designed to test this hypothesis directly, our data do not support such a postulate. We have observed, however, that when endothelial cells and vascular smooth muscle cells are grown together in mixed culture (from four to six passages), muscarinic agonists continue to elicit EDRF release from the endothelium. 15 It is possible that a diffusible factor(s) or matrix produced by the vascular smooth muscle is responsible for maintaining the expression of ml and/or m3 receptors by the endothelium, thus allowing continued release of EDRF in response to muscarinic agonist stimulation. We are investigating this hypothesis currently.
In conclusion, we have demonstrated the presence of mRNA encoding the ml, m2, and m3 muscarinic receptors in freshly isolated endothelial cells. Once placed into culture, however, endothelial cells no longer contain detectable amounts of mRNA for the ml and m3 receptors, whereas they continue to express mRNA for the m2 receptor. These observations provide a possible explanation for why cultured endothelial cells no longer respond to muscarinic agonist stimulation with either a rise in [Ca2"]i or release of EDRF. Assuming that translation of these mRNAs occurs, bovine aortic endothelium contains ml, m2, and m3 muscarinic cholinergic receptors.
